June 7, 2021
Breakthrough Alzheimer’s Drug Makes Early Detection More Important Than Ever

Dear Colleague,

On June 7, the FDA announced the historic fast-tracked approval of Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s disease. This is the first drug to target the pathophysiology of Alzheimer’s and significantly reduce amyloid beta plaque in patients.

There has not been an FDA-approved treatment for the disease since 2003, and we are tremendously delighted by this news.

MoCA Research & Innovation has been working with Biogen, and other major pharma, to not only test and validate treatment options –such as Aducanumab—but to also facilitate rapid comprehensive screening of MCI and early-stage Alzheimer’s among large populations.

Early detection of MCI/Alzheimer’s is imperative to ensure optimal management and outcome. And now, with novel treatments, progression of symptoms and disease conditions can be reduced or halted.

MoCA’s mission has always been to provide the most efficient assessment solutions for earliest diagnosis of MCI, and we are excited to share with you soon the most advanced versions we are working on.

Cheers to you, the medical community.

The MoCA Team

Read full article
April 17, 2021
MoCA best to predict medical decision-making capacity
Read abstract
April 14, 2021
Hyposmia associated with MCI in Covid-19 patients
Read abstract
March 31, 2021
Cognitive impairment may persist 6 months after Covid Infection
Read abstract
March 24, 2021
MoCA sensitive to detect Cannabis related cognitive impairment
Read abstract
March 21, 2021
MoCA useful for longitudinal follow-up of MCI and VCI
Read abstract
February 11, 2021
MoCA useful to detect MCI in patients with Mild Covid
Read abstract
February 5, 2021
T‐MoCA: A valid phone screen for cognitive impairment in diverse community samples
Read abstract
January 2, 2021
MoCA useful in detecting Covid-19 related cognitive impairment.
Read abstract
January 1, 2021
MoCA useful in detecting Covid-19 related cognitive impairment.
Read abstract
December 9, 2020
Utility of MoCA to Predict Amyloid Physiopathology in Mild Cognitive Impairment
Read abstract
August 12, 2020
MoCA Recommended by the American Academy of Family Physicians
Read full article
July 2020
MoCA is the most discriminative tool for screening MCI in the PD population
Read abstract
March 2020
Remote MoCA Testing
Read full article
March 2020
MoCA Best screening test for hemodialysis patients
Read abstract
February 2020
Performing MoCA By Videoconference
Read full article
September 2019
MoCA recommended by AAN for Annual Cognitive Screening for Adults 65+
Read full article
August 2019
MoCA best predictor of cognitive progression in Parkinson
Read abstract
June 2019
Upcoming Mandatory Training for MoCA Testing

It is for our growing community of healthcare professionals that we are now requiring training and certification for test use. In an effort to reduce variability and ensure the highest accuracy, our training and certification program will become mandatory as of September 1, 2019

Read full article
May 2019
MoCA Accurately and Reliably Differentiates VaD and VMCI from Controls
Read abstract
May 2019
International Journal of Geriatric Psychiatry Confirms MoCA Test Accurately and Reliably Differentiates VaD and VMCI from Controls

Based on the available studies, the MoCA is the most accurate and reliable instrument for identifying VCI.

Read full article
March 2019
MoCA: Best Paper and Pencil Test
Read abstract
October 2018
AAN Neurology: Early MoCA predicts long-term cognitive and functional outcome and mortality after stroke
Read abstract
February 2018
Journal of Alzheimer disease: Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study
Read abstract
January 2018
PRNewswire: Trump and MoCA Test : Comments by Dr Ziad Nasreddine Test Creator
Read full article
January 2018
NBC News: Maria Shriver: Why President Trump's cognitive test is a reminder for us all.
Read full article
January 2018
CNN: The MoCA Test: What to Know. This is the cognitive test the president passed.
Read full article
October 2017
MoCA Seen as Most Effective at Measuring Cognitive Problems in Lupus
Read abstract
January 2015
MoCA is Free alternatives comparable to Mini-Mental State Examination
Read abstract
September 2014
MoCA superior to MMSE in Vascular Cognitive Impairment associated with Hypertension
Read abstract
October 2013
MedPage Today : MoCA Beats MMSE to Assess Dementia
Read full article
November 2010
Neurology: The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
Read abstract
September 2006
MoCA Recommended by NIH and CSN for Stroke
Read abstract